ASP Isotopes Provides Details on Merger and Phase 1 Execution
- Aug 3
- 3 min read
ASP Isotopes held an investor call setting out the merger of Noble Africa (the entity holding Renergen) with ENDRA Life Sciences, under which ASPI will own ~89% of the combined company; an S-4 is expected to be filed in early August with completion most likely in Q4’26.